|
Infections Due to Respiratory Syncytial Virus (RSV):
Strategies for Managed Care Organizations to Achieve Optimal
Outcomes
Post Test
A score of 70% must be achieved to receive continuing education
credits.
|
| 1. |
There are four management strategies for
RSV.
True
False |
| 2. |
Each year, an estimated _____
infants in the United States are hospitalized with severe RSV
infections, the leading cause of infant hospitalization in the U.S.
a.
100,000
b.
125,000
c.
150,000
d. 175,000 |
| 3. |
Who is at high risk for severe disease and hospitalization due to
RSV?
a.
Children born prematurely
b.
Chronic lung disease
c.
Congenital
d. All
of the above |
| 4. |
RSV is the most common respiratory infection in infancy or
childhood.
True
False |
| 5. |
Numax is
the only monoclonal antibody approved by the FDA to help prevent an
infectious disease.
True
False |
| 6. |
Synagis is an investigational humanized Mab in phase 3 development
to evaluate its potential to prevent serious lower respiratory tract
disease caused by RSV in pediatric patients at high risk of RSV
disease.
True
False |
| 7 |
____
met its primary enpoint of non-inferiority by reducing the incidence
of hospitalizations caused by RSV in infants at high risk for
serious RSV disease by 26% when compared to _____.
a.
Numax, Synagis
b.
Synagis, Numax
c.
Palavizumab, Motavizumab
d.
None of the above |
|
Activity
Evaluation
Please rate this activity on the following
scale:
4 - Excellent 3 - Good
2 - Fair 1 - Poor |
|
|
|
Due to the content of this activity, I
will change my practice patterns by:
Continuing education implies quality improvement in
behavior. As part of our quality improvement process, NAMCP/AAMCN
will contact you 6 months from your post test submission to monitor
change.
|
|
|